Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19

Overview

Use and content

This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to identify areas that need further attention to enable the facility to respond effectively to the pandemic. The tool encompasses key components that are essential to managing COVID-19 in a hospital setting, including:

• medicines for management of COVID-19 (including the Solidarity clinical trial)
• personal protective equipment
• infection, prevention and control (IPC) supplies
• diagnostic testing, imaging and patient monitoring devices and supplies
• medical equipment for management of COVID-19
• COVID-19 vaccine readiness
• beds and space capacity

Target audiences

The tool is intended to be used by:

• incident management and emergency operation officers
• facility managers
• pharmacists
• biomedical engineers
• IPC officers
• planning officers
• procurement officers
• laboratory staff

Key questions this module helps to answer

The assessment tool is intended to answer the following key questions:

• Do facilities have the necessary diagnostic equipment and supplies for COVID‑19 testing?
• Do facilities have the necessary medicines and medical supplies for the management of COVID‑19 patients?
• Do facilities have the necessary personal protective equipment for health-care workers?
• Do facilities have the necessary IPC supplies?
• Do facilities have a functioning cold chain ready to support potential COVID‑19 vaccination?
• What is the bed and space capacity of the facilities to manage patients affected by COVID‑19?

 

When to use

The tool is designed for use from the early stages of the emergency to early recovery